BNP Paribas Financial Markets’s Myovant Sciences Ltd. MYOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-47,508
Closed -$1.28M 4125
2022
Q4
$1.28M Sell
47,508
-9,797
-17% -$258K ﹤0.01% 2021
2022
Q3
$1.03M Buy
57,305
+30,353
+113% +$485K ﹤0.01% 2465
2022
Q2
$335K Sell
26,952
-45,557
-63% -$503K ﹤0.01% 2867
2022
Q1
$966K Sell
72,509
-13,870
-16% -$186K ﹤0.01% 2345
2021
Q4
$1.34M Buy
86,379
+78,879
+1,052% +$1.51M ﹤0.01% 2380
2021
Q3
$168K Sell
7,500
-178
-2% -$3.91K ﹤0.01% 3105
2021
Q2
$175K Buy
7,678
+3,907
+104% +$82.2K ﹤0.01% 2900
2021
Q1
$77.6K Buy
3,771
+3,686
+4,336% +$83.9K ﹤0.01% 3462
2020
Q4
$2.35K Hold
85
﹤0.01% 3996
2020
Q3
$1.19K Buy
+85
New +$1.58K ﹤0.01% 4080
2020
Q2
Sell
-88
Closed -$664 4413
2020
Q1
$664 Sell
88
-79
-47% -$886 ﹤0.01% 4138
2019
Q4
$2.59K Buy
167
+13
+8% +$131 ﹤0.01% 4208
2019
Q3
$801 Hold
154
﹤0.01% 4409
2019
Q2
$1.39K Buy
154
+93
+152% +$1.39K ﹤0.01% 4353
2019
Q1
$1.46K Hold
61
﹤0.01% 4132
2018
Q4
$1K Sell
61
-39
-39% -$769 ﹤0.01% 3921
2018
Q3
$2.65K Hold
100
﹤0.01% 4220
2018
Q2
$2.29K Hold
100
﹤0.01% 4235
2018
Q1
$2.13K Buy
100
+85
+567% +$1.29K ﹤0.01% 4093
2017
Q4
$190 Hold
15
﹤0.01% 4130
2017
Q3
$232 Hold
15
﹤0.01% 4140
2017
Q2
$176 Sell
15
-31
-67% -$384 ﹤0.01% 4162
2017
Q1
$540 Buy
+46
New +$527 ﹤0.01% 3835

Other funds holding MYOV

BNP Paribas Financial Markets's MYOV Position: Q1 2023 in Review

BNP Paribas Financial Markets sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 47,508 shares — an estimated $1.28M sold.

BNP Paribas Financial Markets first reported a position in MYOV in Q1 2017 and held it in 23 quarters. The position peaked at $1.34M in Q4 2021. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

  • BNP Paribas Financial Markets reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 47,508 Myovant Sciences Ltd. shares in Q1 2023, an estimated $1.28M.
  • BNP Paribas Financial Markets first reported a position in Myovant Sciences Ltd. in Q1 2017 and held it in 23 quarters.
  • BNP Paribas Financial Markets's Myovant Sciences Ltd. position peaked at $1.34M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2023, filed 12 May 2023.